Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 27;18(1):321.
doi: 10.1186/s12885-018-4254-4.

Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages

Eng-Yen Huang  1   2 , Jen-Chieh Chang  3 , Hong-Hwa Chen  4 , Chieh-Ying Hsu  5 , Hsuan-Chih Hsu  5 , Keng-Liang Wu  6
Affiliations

Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages

Eng-Yen Huang et al. BMC Cancer. .

Abstract

Background: We sought to identify the carcinoembryonic antigen (CEA) as a marker of radioresistance in rectal cancer.

Methods: From July 1997 to January 2008, 104 patients with stage II or III rectal cancer who were treated with post-operative radiotherapy (PORT) were included in this study. The doses of radiotherapy ranged from 45 to 54.6 Gy. The CEA levels were measured before surgery. We analyzed the actuarial rates of overall survival (OS), distant metastasis (DM), and local recurrence (LR) using Kaplan-Meier curves. Multivariate analyses were performed with Cox regression models. We used THP-1 monocyte cell lines for macrophage differentiation (M0, M1 or M2). The RNA extracted from the macrophages was analyzed via a genomic method in the core laboratory. The radiosensitivities of CEA-rich LS1034 cells were compared between cells with and without the conditioned media from CEA-stimulated macrophages.

Results: Preoperative CEA levels ≥10 ng/mL were independent predictive factors for OS (p = 0.005), DM (p = 0.026), and LR (p = 0.004). The OS rates among the patients with pretreatment CEA levels < 10 ng/mL and ≥10 ng/mL were 64.5% and 35.9% (p = 0.004), respectively. The corresponding rates of DM were 40.6% and 73.1% (p = 0.024). The corresponding rates of LR were 6.6% and 33.9% (p = 0.002). In the M0 macrophages, exogenous CEA elicited a dose-response relationship with M2 differentiation. In the CEA-stimulated M0 cells, some mRNAs were upregulated by as much as 5-fold, including MMP12, GDF15, and JAG1. In the CEA-stimulated M2 cells, a 4-fold up-regulation of GADD45G mRNA was noted. The conditioned media from the CEA-stimulated M2 cells elicited an increase in the numbers of LS180, SW620, and LS1034 cells after irradiation. CEA caused the M2 differentiation of the macrophages.

Conclusion: Pretreatment CEA levels ≥10 ng/mL are a significant risk factor for OS, DM, and LR following PORT for rectal cancer. CEA causes radioresistance in the presence of M2 macrophages. More comprehensive examinations prior to surgery and intensive adjuvant therapy are suggested for patients with CEA levels ≥10 ng/mL. Further studies of these mechanisms are needed.

Keywords: Carcinoembryonic antigen; Macrophage; Radioresistance; Radiotherapy; Rectal cancer.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Institutional Review Board of Chang Gung Memorial Hospital (99-3189B) approves retrospective studies of routine clinical practice without the informed consent of the patients.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Lower overall survival rate in the patients with CEA levels 3 10 ng/mL
Fig. 2
Fig. 2
Higher distant metastasis rate in the patients with CEA levels 3 10 ng/mL
Fig. 3
Fig. 3
Higher local recurrence rate in the patients with CEA levels 3 10 ng/mL
Fig. 4
Fig. 4
Morphologies of the M0, M1 and M2 macrophages with and without CEA stimulation
Fig. 5
Fig. 5
M1 (CCR7) and M2 (CD163) expression after CEA stimulation of M0 cells
Fig. 6
Fig. 6
Hierarchical clustering of the up- and down-regulated genes (5-fold) after CEA (2 μg/mL) stimulation of M0 macrophages
Fig. 7
Fig. 7
Hierarchical clustering of the up- and down-regulated genes (2-fold) after CEA (2 μg/mL) stimulation of M1 macrophages
Fig. 8
Fig. 8
CEA (320 ng/mL) enhanced the radioresistance of (a) LS180, (b) SW620, and (c) LS1034 cells cultured with M2 conditioned medium. However, CEA did not change radiosensitivity in cancer cells without M2 conditioned medium. Each experimental group included triplicated studies
See this image and copyright information in PMC

References

    1. Chen C, Sun P, Rong J, Weng HW, Dai QS, Ye S. Short course radiation in the treatment of localized rectal cancer: a systematic review and meta-analysis. Sci Rep. 2015;5:10953. doi: 10.1038/srep10953. - DOI - PMC - PubMed
    1. Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, The WCJ. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 2011;81(4):1105–1113. doi: 10.1016/j.ijrobp.2010.07.011. - DOI - PubMed
    1. Yamamoto Y, Hirakawa E, Mori S, Hamada Y, Kawaguchi N, Matsuura N. Cleavage of carcinoembryonic antigen induces metastatic potential in colorectal carcinoma. Biochem Biophys Res Commun. 2005;333(1):223–229. doi: 10.1016/j.bbrc.2005.05.084. - DOI - PubMed
    1. Hefta LJ, Chen FS, Ronk M, Sauter SL, Sarin V, Oikawa S, Nakazato H, Hefta S, Shively JE. Expression of carcinoembryonic antigen and its predicted immunoglobulin-like domains in HeLa cells for epitope analysis. Cancer Res. 1992;52(20):5647–5655. - PubMed
    1. Terskikh A, Mach JP, Pèlegrin A. Marked increase in the secretion of a fully antigenic recombinant carcinoembryonic antigen obtained by deletion of its hydrophobic tail. Mol Immunol. 1993;30(10):921–927. doi: 10.1016/0161-5890(93)90016-5. - DOI - PubMed

Publication types

MeSH terms